OZON & COLON Medizintechnik Inh. Peter Eich
Medical Technology · Reutlingen
OZON & COLON Medizintechnik Inh. Peter Eich is a medical technology company based in Reutlingen, Germany. The company operates in the German medical devices market under the EU Medical Device Regulation (MDR 2017/745).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
OZON & COLON Medizintechnik Inh. Peter Eich Address & Contact
Website
OZON & COLON Medical Technology Overview
OZON & COLON Medical Technology (Inh. Peter Eich) from Reutlingen in Baden-Württemberg is a specialized sole proprietorship focused on the development and distribution of innovative ozone therapy devices as well as colon cleansing systems. Since its founding, the company has dedicated itself to promoting complementary medical approaches and offers its customers high-quality products developed according to the latest scientific standards. Ozone therapy is an alternative treatment method that is gaining importance in naturopathy, with applications ranging from supporting immune function to treating chronic diseases.
Services and Products
OZON & COLON offers an extensive range of products primarily consisting of ozone generators for medical ozone therapy and special colonic irrigation systems for colon hydrotherapy. These devices are designed to meet the highest quality standards and are suitable for professional use in naturopathic practices as well as in complementary medical facilities. The offered consumables include special hoses, filters, and disinfectants that ensure the therapy is conducted in a hygienic environment.
The company pays special attention to training its clients. In addition to product handling, the scientific principles and correct application of the therapeutic approaches are taught to provide therapists with the necessary knowledge to conduct treatments safely and effectively. This not only enhances the quality of the therapies offered but also strengthens patient trust in the respective practice.
Regulatory Classification
The products from OZON & COLON Medical Technology fall within the category of medical devices that are subject to strict regulatory requirements in Germany. The company ensures that all devices and products comply with the Medical Devices Regulation (MDR). This guarantees safe application and a high standard of patient care. Certifications from third-party organizations confirm the quality of the products and strengthen the credibility of the company within the alternative practitioner community and beyond.
Location Reutlingen / Baden-Württemberg
Reutlingen, nestled in the economically dynamic Neckar-Alb region, offers a strategically favorable location for medical technology companies. The region is known not only for its highly developed healthcare infrastructure and universities of applied sciences but also for its proximity to leading research institutions and networks in medical technology. This synergy creates a conducive environment for innovative companies like OZON & COLON, which are experiencing growth and meeting a steadily increasing demand for complementary medical devices in the region.
The connection to surrounding cities such as Stuttgart, Tübingen, and Esslingen also promotes interaction with other medical facilities and professionals. This geographical location allows for easy access to a wide network of doctors, therapists, and entrepreneurs, further supporting the dissemination and use of OZON & COLON products.
Special Features
An outstanding feature of OZON & COLON Medical Technology is its commitment to education and training in the fields of ozone and colon hydrotherapy. The company regularly organizes workshops and seminars that not only explain the functioning of the devices but also the various application fields and best practice methods. This promotes the dissemination and acceptance of these alternative therapies.
Moreover, OZON & COLON places great importance on sustainability and environmental awareness in product development. The materials used are environmentally friendly, and the company aims to minimize environmental impact through efficient manufacturing processes. This philosophy is reflected not only in the management of the company but also in product development, benefiting both therapists and patients.
Further medical technology companies: Medical Technology Overview | Pharmaceutical Companies | Sanitation Houses
```Frequently asked questions about OZON & COLON Medizintechnik Inh. Peter Eich
What does OZON & COLON Medizintechnik Inh. Peter Eich do?
OZON & COLON Medizintechnik Inh. Peter Eich is a company in the medical technology sector based in Reutlingen. The company develops, produces or distributes medical devices, instruments or systems for use in healthcare facilities.
Where is OZON & COLON Medizintechnik Inh. Peter Eich located?
OZON & COLON Medizintechnik Inh. Peter Eich is headquartered in Reutlingen. More information can be found on the company's website.
In which area of medical technology is OZON & COLON Medizintechnik Inh. Peter Eich active?
OZON & COLON Medizintechnik Inh. Peter Eich is active in the medical technology sector and offers solutions for medical facilities, clinics and practices. You can find the exact areas of focus on the company's website.
More Medical Technology in Reutlingen
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.